ABP |
Acute bacterial prostatitis |
ATP |
Adenosine triphosphate |
AUC |
Area under the concentration time curve |
CIP |
Category I prostatitis |
CIIP |
Category II prostatitis |
CBP |
Chronic bacterial prostatitis |
CLSI |
Clinical and laboratory standards institute |
cAMP |
Cyclic adenosine monophosphate |
ECOFF |
Epidemiological cut-off |
EUCAST |
European Committee on Antimicrobial Susceptibility Testing |
ESBL |
Extended spectrum beta-lactamases |
G6P |
Glucose-6-phosphate |
UhpT |
Hexose-6-phosphate transport systems |
IV |
Intra-venous |
GlpT |
L-alpha-glycerophosphate transport system |
MRSA |
Methicillin resistant Staphylococcus aureus
|
MIC |
Minimum inhibitory concentration |
MDR |
Multidrug resistant |
NIH |
National Institutes of Health |
PD |
Pharmacodynamic |
PK |
Pharmacokinetic |
PTS |
Sugar phosphotransferase system |
TURP |
Transurethral resection of the prostate |
UDPMurNAc |
UDP N-acetylmuramic acid |
UNAG |
UDP-N-acetylglucosamine |
UTI |
Urinary tract infections |
Vd |
Volume of distribution |